Cardinal Point Capital Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$216K Buy
+3,200
New +$213K 0.01% 282
2026
Q1
Sell
-3,200
Closed -$212K 293
2025
Q4
$212K Hold
3,200
0.01% 249
2025
Q3
$209K Hold
3,200
0.01% 257
2025
Q2
$279K Hold
3,200
0.02% 189
2025
Q1
$219K Hold
3,200
0.02% 175
2024
Q4
$249K Buy
+3,200
New +$237K 0.04% 76
2023
Q2
Sell
-4,400
Closed -$511K 72
2023
Q1
$511K Buy
4,400
+1,200
+38% +$134K 0.16% 52
2022
Q4
$362K Buy
+3,200
New +$351K 0.13% 50

Other funds holding DXCM

Cardinal Point Capital Management's DXCM Position: Q2 2026 in Review

Cardinal Point Capital Management opened a new position in DexCom (DXCM) in Q2 2026: 3,200 shares worth $216K. The stake represents 0.01% of the portfolio and ranks #282 among its holdings. This is a return to the name: Cardinal Point Capital Management previously reported a position in DXCM as recently as Q4 2025.

Cardinal Point Capital Management first reported a position in DXCM in Q4 2022 and has held it in 8 quarters since. The position peaked at $511K in Q1 2023. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Cardinal Point Capital Management held 3,200 shares of DexCom worth $216K as of Q2 2026.
  • DexCom was a new Cardinal Point Capital Management position in Q2 2026.
  • DexCom made up 0.01% of Cardinal Point Capital Management's portfolio in Q2 2026, its #282 holding.
  • Cardinal Point Capital Management first reported a position in DexCom in Q4 2022 and has held it in 8 quarters since.
  • Cardinal Point Capital Management's DexCom position peaked at $511K in Q1 2023.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Cardinal Point Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.